Skip to main content

Jaipur

 

Clinical courses

  • PharmaTutor Magazine - June 2015 is released | Read online or Subscribe

  • Faculty - Paramedical Lecturer / Professor in Client of 7 Colors Consultants

    Our Client is one of the leader in Health Care /Medical Industry

    Post: Faculty - Paramedical Lecturer / Professor

  • Career as Area Business Manager in Jenome Biophar

    We, Jenome Biophar recognize itself as a business organization with a mission, not merely an entity that exists to generate profit. This mission describes the road map towards reaching long-term objectives and establishing the organization's future vision. Moreover, it highlights the basis and values that control business conduct on all levels.
    Moreover, a clear future vision accessible to all company employees is an important element in portraying the desired shape of the organization in the future and therefore inspires, motivates and improves performance. This is why we keep our mission and vision in mind and heart at all times.
    We, Jenome Oncology, are dedicated to anticancer range of products. We are dealing in almost all chemotherapeutic range of products as well as we also deal in unique & specialized anti cancer range of products. We are the pioneer in our special range of products which we had launched first time in India.

    Post: Area Business Manager

  • Opportunity for Medical Representative in Leading Pharma Company Nextus Solution

    Leading Pharma Company

    Post: Medical Representative

  • PharmaTutor Magazine - May 2015 is released | Read online and Subscribe

  • Jaipur National University invites Faculty positions

    Jaipur National University, Jaipur, a Private self- financed University, sponsored by Mahima Shiksha Samiti, Came into existence on October 22, 2007 through an Ordinance of the government of Rajasthan. Jaipur National University is one of the many institutions of the Seedling Group of educational Institutions of the Mahima Shiksha Samiti.

    Invites applications for the posts of Professors/ Associate Professors/ Assistant Professors in the following disciplines

    Post: Professors/ Associate Professors/ Assistant Professors

  • MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3
    1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
    2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
    3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
    sureshrewar1990@gmail.com

    ABSTRACT
    A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.

  • MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

    ABOUT AUTHORS:
    Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3
    1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
    2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
    3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
    sureshrewar1990@gmail.com

    ABSTRACT
    A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.

  • Application are invited for Pharmacist in JNU | 12 Posts

    Jaipur National University, Jaipur, a Private self- financed University, sponsored by Mahima Shiksha Samiti, Came into existence on October 22, 2007 through an Ordinance of the government of Rajasthan. Jaipur National University is one of the many institutions of the Seedling Group of educational Institutions of the Mahima Shiksha Samiti.

  • Applications invited for Pharma Management faculties at IIHMR University

    IIHMR University Is a specialised Research University in management research, postgraduate education and training exclusively in the health sector. The IIHMR University has established the discipline of health management and set the national agenda lor policy and program and health systems research in the health sector. It is a WHO Collaborating Centre for district health systems and designated as an Institute of Excedence in India for training and capacity.

    Invites Applications For Associate Professor AND Assistant Professor In Following Areas:

    Post: Associate Professor, Assistant Professor

Subscribe to Jaipur